|
Resistance rate (%)
|
|---|
|
Isolate/Antibiotics
|
2008–2011
|
2012–2015
|
Total
|
P for Trend Test
|
|
All Escherichia coli
|
|
AMK
|
7.78
|
14.16
|
11.33
|
0.154
|
|
AMP
|
97.92
|
96.49
|
97.14
|
0.537
|
|
SAM
|
81.97
|
87.93
|
85.88
|
0.279
|
|
TZP
|
23.47
|
25.00
|
24.30
|
0.795
|
|
CZO
|
92.55
|
91.30
|
91.87
|
0.742
|
|
CAZ
|
81.82
|
69.83
|
75.35
|
0.042
|
|
FEP
|
75.51
|
62.07
|
68.22
|
0.035
|
|
IPM
|
14.29
|
25.86
|
20.56
|
0.037
|
|
CIP
|
90.16
|
79.13
|
82.95
|
0.064
|
|
ESBL+
|
|
AMK
|
6.78
|
12.33
|
9.85
|
0.287
|
|
AMP
|
100.00
|
100.00
|
100.00
|
–
|
|
SAM
|
77.78
|
93.15
|
88.07
|
0.020
|
|
TZP
|
20.31
|
6.85
|
13.14
|
0.020
|
|
SXT
|
84.21
|
73.61
|
77.27
|
0.207
|
|
CZO
|
100.00
|
100.00
|
100.00
|
–
|
|
CAZ
|
89.23
|
68.49
|
78.26
|
0.003
|
|
FEP
|
81.25
|
60.27
|
70.07
|
0.007
|
|
IPM
|
12.31
|
8.22
|
10.14
|
0.427
|
|
CIP
|
86.11
|
80.82
|
82.57
|
0.494
|
|
ESBL-
|
|
AMK
|
6.67
|
16.22
|
13.46
|
0.361
|
|
AMP
|
88.24
|
89.74
|
89.29
|
0.867
|
|
SAM
|
77.78
|
77.50
|
77.55
|
0.986
|
|
ZP
|
35.29
|
57.50
|
50.88
|
0.125
|
|
SXT
|
88.89
|
67.50
|
71.43
|
0.199
|
|
CZO
|
58.82
|
74.36
|
69.64
|
0.245
|
|
CTT
|
28.57
|
70.00
|
63.83
|
0.035
|
|
CAZ
|
52.94
|
70.00
|
64.91
|
0.217
|
|
FEP
|
52.94
|
62.50
|
59.65
|
0.501
|
|
IPM
|
43.75
|
57.50
|
53.57
|
0.351
|
|
CIP
|
88.89
|
77.50
|
79.59
|
0.444
|
|
Not all tested antibiotics are listed
|
-
AMK Amikacin, AMP Ampicillin, SAM Ampicillin/Sulbactam, CAZ Ceftazidime, efepime, CTT Cefotetan, CZO Cefazolin, IPM Imipenem, TZP Piperacillin-Tazobactam, CIP Ciprofloxacin
- Data in boldface reflected p values < 0.05
